CXCR2 Inhibition to Combat Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 100卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [41] CXCR2/CXCR2 ligand biology ischemia-reperfusion injury
    Belperio, JA
    Keane, MP
    Burdick, MD
    Gomperts, BN
    Xue, YY
    Hong, K
    Mestas, J
    Zisman, D
    Ardehali, A
    Saggar, R
    Lynch, JP
    Ross, DJ
    Strieter, RM
    JOURNAL OF IMMUNOLOGY, 2005, 175 (10): : 6931 - 6939
  • [42] The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma
    Mestas, J
    Burdick, MD
    Reckamp, K
    Pantuck, A
    Figlin, RA
    Strieter, RM
    JOURNAL OF IMMUNOLOGY, 2005, 175 (08): : 5351 - 5357
  • [43] Pancreatic Ductal Adenocarcinoma Derived From IPMN and Pancreatic Ductal Adenocarcinoma Concomitant With IPMN
    Yamaguchi, Koji
    Kanemitsu, Shuichi
    Hatori, Takashi
    Maguchi, Hiroyuki
    Shimizu, Yasuhiro
    Tada, Minoru
    Nakagohri, Toshio
    Hanada, Keiji
    Osanai, Manabu
    Noda, Yutaka
    Nakaizumi, Akihiko
    Furukawa, Toru
    Ban, Shinichi
    Nobukawa, Bunsei
    Kato, Yo
    Tanaka, Masao
    PANCREAS, 2011, 40 (04) : 571 - 580
  • [44] Inhibition of CXCR2 attenuates bronchial angiogenesis in the ischemic rat lung
    Sukkar, Adlah
    Jenkins, John
    Sanchez, Jesus
    Wagner, Elizabeth M.
    JOURNAL OF APPLIED PHYSIOLOGY, 2008, 104 (05) : 1470 - 1475
  • [45] Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia
    Umesh K Bhanot
    Hepatobiliary&PancreaticDiseasesInternational, 2008, (01) : 106 - 107
  • [46] Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia
    Bhanot, Umesh K.
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2008, 7 (01) : 106 - 107
  • [47] Tumor-selective inhibition of active RAS in pancreatic ductal adenocarcinoma
    Wasko, Urszula N.
    Jiang, Jingjing
    Tomassoni, Lorenzo
    Wang, Yingyun
    Lee, Bianca
    Orlen, Margo
    Drizyte-Miller, Kristina
    Menard, Marie
    Dilly, Julien
    Sastra, Steven A.
    Palermo, Carmine F.
    Chang, Stephanie
    Aguirre, Andrew J.
    Der, Channing J.
    Vonderheide, Robert H.
    Stanger, Ben Z.
    Califano, Andrea
    Singh, Mallika
    Olive, Kenneth P.
    CANCER RESEARCH, 2024, 84 (02)
  • [48] Inhibition of STAT3 in pancreatic ductal adenocarcinoma and immunotherapeutic implications
    Zielinski, Rafal
    Fokt, Izabela
    Skora, Stanislaw
    Felix, Edward
    Grela, Krzysztof
    Arumugam, Jayakumar
    Venugopal, Radj
    Ai, Midan
    Hartley, Genevieve
    Curran, Michael
    Priebe, Waldemar
    CANCER RESEARCH, 2019, 79 (13)
  • [49] Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis
    Kerstetter, A. E.
    Padovani-Claudio, D. A.
    Bai, L.
    Miller, R. H.
    EXPERIMENTAL NEUROLOGY, 2009, 220 (01) : 44 - 56
  • [50] Preclinical evaluation of Bmi1 inhibition in pancreatic ductal adenocarcinoma
    Eberle, Jaime A.
    Yuan, Haoxuan
    Palermo, Carmine
    Sastra, Stephen A.
    Cao, Liangxian
    Moon, Young-choon
    Dumble, Melissa
    Davis, Thomas
    Olive, Kenneth P.
    MOLECULAR CANCER RESEARCH, 2016, 14
12345